Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicinesMembers leverage AI-powered dataset to accelerate ...
Alnylam Pharma joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine: San Diego Saturday, September 20, 2025, 12:00 Hrs [IST ...
Members leverage AI-powered dataset to accelerate pharma R&D, and ensure that disease-impacting discoveries benefit all ...
The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period. This ...
According to Precedence Research, the global liquid biopsy market size will grow from USD 7.05 billion in 2025 to nearly USD ...
The global ovarian cancer diagnostics market is set to witness a growth rate of ~6% in the next 5 years. Rising incidence of ...
Medical technology companies are facing the type of patent litigation once reserved for tech giants, and they’re responding ...
The global Triple X Syndrome Management Market is poised for significant growth over the next decade, with projections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback